| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,649 |
3,334 |
$483K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,412 |
7,651 |
$335K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,082 |
4,490 |
$253K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,533 |
4,114 |
$184K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,918 |
1,823 |
$142K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
11,280 |
5,046 |
$129K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,902 |
1,773 |
$128K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,008 |
3,744 |
$104K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,208 |
1,150 |
$92K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
977 |
942 |
$81K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,756 |
3,449 |
$49K |
| 99381 |
|
502 |
467 |
$32K |
| 99383 |
|
320 |
308 |
$27K |
| 31720 |
|
605 |
405 |
$26K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,992 |
2,185 |
$24K |
| 99382 |
|
205 |
191 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
310 |
298 |
$17K |
| 87807 |
|
1,365 |
1,282 |
$14K |
| 99384 |
|
131 |
128 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
417 |
392 |
$9K |
| 90461 |
|
1,535 |
768 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
68 |
65 |
$6K |
| 83655 |
|
434 |
411 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
410 |
394 |
$4K |
| 99429 |
|
95 |
94 |
$3K |
| 92558 |
|
994 |
898 |
$3K |
| 0071A |
|
55 |
55 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
52 |
51 |
$2K |
| 0072A |
|
44 |
44 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
125 |
124 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$1K |
| 85018 |
|
437 |
415 |
$807.94 |
| 99442 |
|
15 |
14 |
$553.35 |
| 0001A |
|
14 |
14 |
$520.00 |
| 99177 |
|
75 |
68 |
$437.50 |
| 99174 |
|
67 |
53 |
$367.50 |
| 99441 |
|
26 |
25 |
$319.02 |
| 36415 |
Collection of venous blood by venipuncture |
547 |
509 |
$175.00 |
| 96380 |
|
104 |
85 |
$58.04 |
| 94760 |
|
224 |
208 |
$55.05 |
| 99173 |
|
1,454 |
1,324 |
$49.00 |
| 90686 |
|
1,238 |
1,190 |
$23.51 |
| 90633 |
|
943 |
893 |
$19.25 |
| 91307 |
|
111 |
103 |
$14.57 |
| 90677 |
|
914 |
863 |
$3.39 |
| 90697 |
|
738 |
692 |
$2.46 |
| 90619 |
|
70 |
66 |
$0.40 |
| 90620 |
|
125 |
122 |
$0.24 |
| 90734 |
|
239 |
232 |
$0.15 |
| 90651 |
|
544 |
517 |
$0.14 |
| 90381 |
|
83 |
62 |
$0.11 |
| 90380 |
|
21 |
20 |
$0.06 |
| 90670 |
|
916 |
871 |
$0.03 |
| 90648 |
|
178 |
165 |
$0.01 |
| 90681 |
|
62 |
58 |
$0.01 |
| 90723 |
|
148 |
141 |
$0.01 |
| 90710 |
|
549 |
515 |
$0.00 |
| 90715 |
|
142 |
140 |
$0.00 |
| 90707 |
|
113 |
102 |
$0.00 |
| 90700 |
|
66 |
57 |
$0.00 |
| 90713 |
|
41 |
34 |
$0.00 |
| 91300 |
|
23 |
21 |
$0.00 |
| 96127 |
|
470 |
424 |
$0.00 |
| 90696 |
|
173 |
157 |
$0.00 |
| 90698 |
|
663 |
632 |
$0.00 |
| 90656 |
|
272 |
260 |
$0.00 |
| 90716 |
|
131 |
116 |
$0.00 |
| 90680 |
|
919 |
855 |
$0.00 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
40 |
38 |
$0.00 |
| 36416 |
|
111 |
99 |
$0.00 |
| 90744 |
|
76 |
73 |
$0.00 |